Detalhe da pesquisa
1.
Letter to the Editors regarding "10% body weight (gain) change as criterion for the maximum tolerated dose: A critical analysis".
Regul Toxicol Pharmacol
; 143: 105440, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37453555
2.
The effect of a selective CXCR2 antagonist (AZD5069) on human blood neutrophil count and innate immune functions.
Br J Clin Pharmacol
; 80(6): 1324-36, 2015 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-26182832
3.
Exploration of the GARD™skin applicability domain: Indirectly acting haptens, hydrophobic substances and UVCBs.
ALTEX
; 40(1): 53-60, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-35502631
4.
The chemokine CXCR2 antagonist (AZD5069) preserves neutrophil-mediated host immunity in non-human primates.
Haematologica
; 102(2): e65-e68, 2017 02.
Artigo
Inglês
| MEDLINE | ID: mdl-27742769
5.
Recent developments in the risk assessment of potentially genotoxic impurities in pharmaceutical drug substances.
Toxicol Sci
; 100(1): 24-8, 2007 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-17656486
6.
A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity.
Regul Toxicol Pharmacol
; 44(3): 198-211, 2006 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-16412543